
Sign up to save your podcasts
Or


Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune diseases by neutralizing causal factors encoded by Human Endogenous Retroviruses.
By John Simboli5
77 ratings
Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune diseases by neutralizing causal factors encoded by Human Endogenous Retroviruses.

3,072 Listeners

1,955 Listeners

1,095 Listeners

2,353 Listeners

948 Listeners

790 Listeners

124 Listeners

322 Listeners

6,069 Listeners

94 Listeners

10,019 Listeners

525 Listeners

151 Listeners

248 Listeners

187 Listeners